blog
Farm bill delivers victory for veterinary medicine
The nation’s new farm bill creates critical programs to improve animal health and enhance the nation’s ability to prevent and respond to animal…
blog
Amoxicillin: Will a human drug shortage affect veterinarians?
A shortage of some amoxicillin products used in human medicine could affect veterinarians who use the drugs in an extra-label manner. No shortage of…
blog
New report informs competitive business strategy and career decisions
This new report breaks down AVMA’s most recent economic research into actionable takeaways you can use to build and support your business. Find key…
blog
AVMA working group helps navigate opioid abuse epidemic
An AVMA working group has taken up the task of providing needed information to help veterinary professionals contribute productively to the national…
blog
DEA provides update on opioid shortage
The U.S. Drug Enforcement Administration (DEA) released a statement last week on the ongoing opioid shortages affecting both human and veterinary…
blog
How to simplify and optimize purchasing
Direct Connect is a powerful, free, member-exclusive tool that simplifies and optimizes the purchasing process for veterinary practices. Learn how to…
blog
Congratulations are in order!
Two veterinarians and a former director of the California Veterinary Medical Association have been named as recipients of 2021 AVMA Excellence Awards…
blog
New FDA guidance addresses medically important antimicrobials
The U.S. Food and Drug Administration (FDA) has released new guidance to facilitate veterinary oversight of all animal antimicrobial drugs considered…
blog
AVMA prepares response to FDA draft compounding guidance
Based on feedback from member veterinarians and other stakeholders, the AVMA has compiled a list of key points to share with the FDA in our formal…
blog
Opioid manufacturing quotas could limit access in 2020
Veterinary access to five Schedule II opioids could be reduced next year under a proposal by the U.S. Drug Enforcement Administration (DEA) to limit…
blog
Explore cannabis topics in depth with experts
AVMA's first-ever symposium on veterinary cannabis will provide a 360-degree perspective, presented directly by key leaders in research, practice and…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
blog
Business forecast: Change mixed with stability
Veterinary practitioners can expect to see permanent changes in client preferences coming out of the COVID-19 pandemic. Here’s how you can look to…
blog
Kudos! Veterinary researchers chosen to receive grants
Three veterinary researchers have been named recipients of research grants awarded by the American Veterinary Medical Foundation in partnership with…
blog
Report identifies antimicrobial-resistant pathogens impacting animal health
A new report on antimicrobial-resistant pathogens and their impact on animal health is now available for AVMA members to download.
blog
Antimicrobial resistance: Slowing and limiting its emergence and spread
As a practice owner, I have been struck by the number of antimicrobial-resistant bacterial infections my team and I have seen in our patients.
blog
Cannabis: Lead & learn from AVMA experts
Webinar offers education and guidance on timely topic If you were one of the 800-plus veterinary professionals who attended the AVMA’s recent webinar…
blog
Pentobarbital back orders and potential alternatives
AVMA has received reports of short-term back orders of pentobarbital. While avenues to resolve are being explored, here are possible alternatives for…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
blog
February webinars: Strengthen your team and reputation
As veterinarians, we rely on many different tools and resources to help us succeed as doctors and professionals. But when these tools aren’t used to…